AOUL
OGN icon

ALL OPTIONS USA, LLC’s Organon & Co OGN Stock Holding History

ALL OPTIONS USA, LLC’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$425 Buy
+31
New +$423 ﹤0.01% 1498

Other funds holding OGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Soros Fund Management
Soros Fund Management New York $8.51B AUM 25.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

ALL OPTIONS USA, LLC's OGN Position: Q3 2026 in Review

ALL OPTIONS USA, LLC opened a new position in Organon & Co (OGN) in Q3 2026: 31 shares worth $425. The stake represents ﹤0.01% of the portfolio and ranks #1498 among its holdings.

507 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • ALL OPTIONS USA, LLC held 31 shares of Organon & Co worth $425 as of Q3 2026.
  • Organon & Co was a new ALL OPTIONS USA, LLC position in Q3 2026.
  • Organon & Co made up ﹤0.01% of ALL OPTIONS USA, LLC's portfolio in Q3 2026, its #1498 holding.
  • 507 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on ALL OPTIONS USA, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.